Original release date: April 29, 2020
Access to this course expires on: November 6, 2022 at 11:59 PM Pacific Time
CME 13.25 | SAM 9
Gynecologic pathology is a large sub-specialty area covering numerous sites, diseases and cancers. Due to the breadth of this field, many nuanced details regarding classification of disease, intra-operative consultation, newly described tests and staging of gynecologic cancer remain unknown to many surgical pathologists. Most practicing surgical pathologists see ample amounts of gynecologic surgical pathology on a routine basis including biopsy material, specimens for intra-operative consultation and cancer resections which require laboratory work-up and assessment of important staging pathologic variables. Such complexity makes it essential that some of the intricacies of this field be discussed. The aim of this course will be to discuss some of the more difficult specimens encountered within this discipline, as well as new clinical tests that have become available. In addition, portions of the course will address chronically difficult staging issues that are commonly encountered.
Practicing academic and community pathologists, and pathologists-in-training
Upon completion of this educational activity, learners will be able to:
- List and describe common problems encountered in diagnosing, grading and staging endometrial adenocarcinoma
- List and describe common problems encountered in diagnosing and grading cervical carcinoma
- Describe histologic and molecular features of uterine mesenchymal tumors
- Describe the approach to diagnosis in abnormal products of conception specimens
Continuing Medical Education and Continuing Certification
The United States and Canadian Academy of Pathology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The United States and Canadian Academy of Pathology designates this enduring material for a maximum of 13.25 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
USCAP is approved by the American Board of Pathology (ABPath) to offer Self-Assessment credits (SAMs) and Lifelong Learning (Part II) credit for the purpose of meeting the ABPath requirements for Continuing Certification (CC). Registrants must take and pass the post-test in order to claim SAMs credit. Physicians can earn a maximum of 9 SAM/Part II credit hours.
The faculty, committee members, and staff who are in position to control the content of this activity are required to disclose to USCAP and to learners any relevant financial relationship(s) of the individual or spouse/partner that have occurred within the last 12 months with any commercial interest(s) whose products or services are related to the CME content. USCAP has reviewed all disclosures and resolved or managed all identified conflicts of interest, as applicable.
The following faculty and IM Coordinator reported relevant financial relationships: Charles Matthew Quick, MD: Consultant, Allergan; Joseph T. Rabban, MD, MPH: Spouse Employee, Merck and Co.
The following faculty reported no relevant financial relationships: Vinita Parkash, MBBS, Carlos Parra-Herran, MD
The following IM Coordinator who planned and reviewed content for this activity reported no relevant financial relationships: Steven D. Billings, MD
USCAP staff associated with the development of content for this activity reported no relevant financial relationships.
To earn CME and SAM credit, all learners must complete the evaluation. View and print your certificate by clicking here .
Buy the entire Interactive Uterine Pathology course and get a great discount!
Not A Member? Click Here